Analysis of the pharmacological mechanism of Roucongrong in treating osteoporosis based on a biological network module

被引:0
|
作者
Lin, De-Min [1 ]
Xie, Xing-Wen [2 ,3 ]
Li, Ding-Peng [2 ,3 ]
Xu, Wei [4 ]
Li, Jing [4 ]
Lu, He-Zhong [5 ]
Huang, Rui [1 ]
机构
[1] Gansu Univ Tradit Chinese Med, Lanzhou 730000, Gansu, Peoples R China
[2] Affiliated Hosp Northwest Minzu Univ, 1 Hezheng West Rd, Lanzhou 730000, Gansu, Peoples R China
[3] Second Peoples Hosp Gansu Prov, Lanzhou 730000, Gansu, Peoples R China
[4] Gansu Prov Hosp Tradit Chinese Med, Lanzhou 730000, Gansu, Peoples R China
[5] Huaying Second Peoples Hosp, Guangan 835000, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Roncongrong; osteoporosis; network pharmacology; signal pathway; target; module analysis; OSTEOBLAST; OSTEOCLASTOGENESIS; DIFFERENTIATION; SUPPRESSION; EXPRESSION; CYTOKINES; ACTIVATOR; PROMOTES; GENE; AKT1;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The network pharmacology method can be used to predict the active components, targets, and key signal transduction pathways of Roucongrong. This method has been explored in the treatment of osteoporosis. Methods: The effective ingredients and targets of Roucongrong were obtained by searching the TCMSP database. By combining OMIM, and the GeneCards database, the disease targets of osteoporosis were obtained. We determined the common goals of drugs and diseases and performed PPI network analysis on the STRING platform. The obtained data was constructed using Cytoscape software to construct a network module to perform functional annotation of GO terminology and analysis of the KEGG signal path. Results: A total of 6 active ingredients were screened and identified from Roucongrong, and 223 potential targets of the active ingredients were identified from traditional Chinese medicine. In addition, we found 1086 osteoporosis-related targets in two complete databases, and determined the intersection of disease targets and potential targets of the active ingredients; a total of 59 common targets were identified. The results show that the mechanism of Roucongrong in the treatment of osteoporosis is related to aging, response to drug, angiogenesis, positive regulation of gene expression, extracellular space, extracellular region, cytokine activity, and enzyme binding, mainly through Rheumatoid arthritis, Chagas disease (American trypanosomiasis) and Pathways in cancer to achieve the therapeutic effect. Conclusions: The mechanism of Roucongrong in the treatment of osteoporosis is directly or indirectly related to multiple signaling pathways, mainly involving aging and cytokine activity, as well as response to drug, angiogenesis, positive regulation of gene expression, extracellular space, extracellular region, and enzyme binding, etc. Systematic comprehensive intervention is used to achieve the effect of treating osteoporosis. It provides a theoretical reference for further research on the material basis and mechanism of action of Roucongrong on anti-osteoporosis.
引用
收藏
页码:2359 / 2368
页数:10
相关论文
共 50 条
  • [1] Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module
    Yu, Ying
    Zhang, Gong
    Han, Tao
    Huang, Hailiang
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 199
  • [2] Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module
    Ying Yu
    Gong Zhang
    Tao Han
    Hailiang Huang
    BMC Complementary Medicine and Therapies, 20
  • [3] Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
    Xiong, Zhencheng
    Zheng, Can
    Chang, Yanan
    Liu, Kuankuan
    Shu, Li
    Zhang, Chi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [4] Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis
    Fan, Jiashuang
    Zhou, Jianli
    Qu, Zhuan
    Peng, Hangya
    Meng, Shuhui
    Peng, Yaping
    Liu, Tengyan
    Luo, Qiu
    Dai, Lifen
    FRONTIERS IN GENETICS, 2022, 13
  • [5] Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
    Wang, Xiqoqiang
    Li, Hongtao
    Long, Longhai
    Song, Chao
    Chen, Rui
    Pan, Hongyu
    Qiu, Junjie
    Liu, Bing
    Liu, Zongchao
    MEDICINE, 2023, 102 (42) : E34773
  • [6] Analysis of Puerarin's Mechanism in Treating Diabetic Osteoporosis by using Network Pharmacology
    Chen, Yuwei
    Sun, Qiyuan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 (04) : 10 - 19
  • [7] Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology
    ZHOU Hao-Nan
    LI Hao-Yu
    XU Wen-Hua
    WEI Yan-Yi
    YU Rui-Xin
    WANG Wei
    CHEN Yuan-Ming
    Chinese Journal of Natural Medicines, 2021, 19 (01) : 28 - 35
  • [8] Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology
    Zhou Hao-Nan
    Li Hao-Yu
    Xu Wen-Hua
    Wei Yan-Yi
    Yu Rui-Xin
    Wang Wei
    Chen Yuan-Ming
    CHINESE JOURNAL OF NATURAL MEDICINES, 2021, 19 (01) : 28 - 35
  • [9] Decoding the mechanism of Eleutheroside E in treating osteoporosis via network pharmacological analysis and molecular docking of osteoclast-related genes and gut microbiota
    Zhou, Tianyu
    Zhou, Yilin
    Ge, Dongdong
    Xie, Youhong
    Wang, Jiangyan
    Tang, Lin
    Dong, Qunwei
    Sun, Ping
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation
    Hou, Xianbing
    Chen, Dandan
    Wang, Yao
    Cui, Bixian
    Xu, Hui
    Wang, Yuanyuan
    Chen, Hongzhou
    Wang, Dan
    Chen, Ying
    Cheng, Tongfei
    Dai, Xiaojun
    MEDICINE, 2023, 102 (20) : E33825